cytolytic effects on leukemic cells
Showing 1 - 25 of >10,000
"Peripheral Blood Dipeptidylpeptidase IV Positive Leukemic Stem
Not yet recruiting
- Chronic Myeloid Leukemia, Chronic Phase
-
Sohag, EgyptSohag University Hospital
Sep 14, 2022
Refractory Leukemia, Relapsed Leukemia, Acute Myelogenous Leukemia Trial in Miami (STING-Dependent Activators (STAVs) Loaded
Not yet recruiting
- Refractory Leukemia
- +4 more
- STING-Dependent Activators (STAVs) Loaded Autologous Leukemic Cells
- Dendritic Cell Vaccine
-
Miami, FloridaUniversity of Miami
Jan 23, 2023
Chronic Lymphocytic Leukemia Trial in Madison ([U-13C]glucose, [13C5]glutamine)
Recruiting
- Chronic Lymphocytic Leukemia
- [U-13C]glucose
- [13C5]glutamine
-
Madison, WisconsinUniversity of Wisconsin
Jun 15, 2022
Chronic Myeloid Leukemia Trial in New York (Nilotinib)
Completed
- Chronic Myeloid Leukemia
-
New York, New YorkWeill Cornell Medical College
Mar 24, 2022
Acute Myeloid Leukemia Trial in Besançon (Sample collection)
Recruiting
- Acute Myeloid Leukemia
- Sample collection
-
Besançon, FranceCHU Besançon
Jan 29, 2021
Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in
Suspended
- Juvenile Myelomonocytic Leukemia
- +27 more
- CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 11, 2023
Acute Myeloid Leukemia At Initial Diagnosis and/or Relapse in
Not yet recruiting
- Acute Myeloid Leukemia
- Genetic Predisposition to Disease
- Collection of blood sample of bone marrow (cohort 1)
- Collection of blood sample of bone marrow (cohort 2 and 3)
- (no location specified)
Mar 6, 2023
Myeloproliferative Tumor, Secondary Leukemia Trial (Multiomic characterization, In vitro drug screening)
Not yet recruiting
- Myeloproliferative Neoplasm
- Secondary Leukemia
- Multiomic characterization
- In vitro drug screening
- (no location specified)
Aug 28, 2023
Neuromyelitis Optica Trial in Bron, Strasbourg (Blood sampling)
Recruiting
- Neuromyelitis Optica
- Blood sampling
-
Bron, France
- +1 more
Mar 29, 2022
B Cell Leukemia Trial in Seattle (Autologous CD19 CAR+ EGFTt + T cells)
Active, not recruiting
- B Cell Leukemia
- Autologous CD19 CAR+ EGFTt + T cells
-
Seattle, WashingtonSeattle Children's Hospital
Feb 15, 2022
Bone Marrow Transplant Infection, Bronchiolitis Obliterans, Chronic Respiratory Insufficiency Trial in Paris (late pulmonary
Completed
- Bone Marrow Transplant Infection
- +4 more
- late pulmonary complications occurring in children treated with allogeneic hematopoietic stem cells.
-
Paris, FranceHoudouin véronique
Apr 28, 2020
Myeloproliferative Tumor Trial (BCR-ABL gene PCR)
Unknown status
- Myeloproliferative Neoplasm
- BCR-ABL gene PCR
- (no location specified)
Mar 16, 2020
NSCLC, Immunotherapy Trial in Ann Arbor (Dexamthasone)
Terminated
- Non-Small Cell Lung Cancer
- Immunotherapy
-
Ann Arbor, MichiganVA Ann Arbor Healthcare System, Ann Arbor, MI
Jan 6, 2023
Chronic Myeloid Leukemia Trial in France (biological samples)
Completed
- Chronic Myeloid Leukemia
- biological samples
-
Belfort, France
- +3 more
May 31, 2022
AML/MDS Trial in Copenhagen (iDLI)
Recruiting
- AML/MDS
- iDLI
-
Copenhagen, DenmarkCopenhagen University Hospital, Rigshospitalet
Jan 13, 2023
Cancer, MDS-EB, MDS Trial in Athens, Southampton, Sheffield (INKmune)
Recruiting
- Cancer
- +4 more
- INKmune
-
Athens, Attiki, Greece
- +2 more
Jul 3, 2023
Acute Myeloid Leukemia Trial in Bolzano, Castelfranco Veneto (Adrenomedullin)
Recruiting
- Acute Myeloid Leukemia
- Adrenomedullin
-
Bolzano, Italy
- +1 more
Aug 16, 2021
Leukemia Trial (90-Yttrium-labelled anti-CD66 mAb)
Not yet recruiting
- Leukemia
- 90-Yttrium-labelled anti-CD66 monoclonal antibody
- (no location specified)
Aug 16, 2022
Refractory Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia Trial in Saint Louis (biological, drug, procedure)
Not yet recruiting
- Refractory Acute Myeloid Leukemia
- Relapsed Acute Myeloid Leukemia
- Cytokine induced memory-like NK cells
- +5 more
-
Saint Louis, MissouriWashington University School of Medicine
Jun 30, 2022
Chronic Myeloid Leukemia Patients With Major Molecular Response
Unknown status
- Chronic Myeloid Leukemia
-
Ankara, TurkeyAnkara University
Sep 25, 2019
Acute Leukemia, in Relapse, Acute Leukemia Refractory Trial in Suzhou (CVA regimen bridging to HSCT)
Recruiting
- Acute Leukemia, in Relapse
- Acute Leukemia Refractory
- CVA regimen bridging to HSCT
-
Suzhou, Jiangsu, ChinaThe First Affliated Hospital of Soochow University
Jan 4, 2022
Interplay Between Immune and Metabolic Programs in
Recruiting
- Myelodysplastic Syndromes
-
Toulouse, FranceIUCT-Oncopole University Hospital
May 17, 2022
Acute Myeloid Leukemia Trial in Beijing, Shenzhen, Haikou (CLL-1, CD33, CD38 and/or CD123-specific universal CAR- T cells)
Recruiting
- Acute Myeloid Leukemia
- CLL-1, CD33, CD38 and/or CD123-specific universal CAR- T cells
-
Beijing, Beijing, China
- +2 more
Aug 8, 2023
Leukemia, Acute Lymphoblastic Leukemia Trial in New York (gene-modified T cells targeted)
Active, not recruiting
- Leukemia
- Acute Lymphoblastic Leukemia
- gene-modified T cells targeted
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Feb 1, 2023
Acute Myeloid Leukemia Trial (NK cells, Talazoparib 1 MG [Talzenna])
Not yet recruiting
- Acute Myeloid Leukemia
- NK cells
- Talazoparib 1 MG [Talzenna]
- (no location specified)
Jan 9, 2023